HCPCS code J3411: Thiamine HCl 100 mg billing guide

Key Takeaways

HCPCS code J3411 describes injection of thiamine hydrochloride (vitamin B1), 100 mg, administered intramuscularly or intravenously

One unit = 100 mg; billing multiple units requires documented dose justification and accurate unit reporting on the claim

Modifiers JW and JZ are required for Medicare claims: JW for discarded drug waste, JZ when no drug is wasted

Pabau’s claims management software helps IV therapy and integrative medicine practices track J-code billing, modifiers, and NDC reporting in one workflow

HCPCS code J3411 is the Centers for Medicare and Medicaid Services (CMS) Level II code for injection of thiamine hydrochloride 100 mg. It covers both intramuscular (IM) and intravenous (IV) routes of administration. The code is active for fiscal year 2026 with no descriptor change from the prior year.

Practices billing for injectable nutritional therapies, including those using IV therapy EMR software, should confirm that J3411 is correctly mapped in their drug catalog before submission. A mismatch between the administered drug and the HCPCS code is a primary source of claim rejection.

Clinical overview: Thiamine HCl and its medical uses

Thiamine hydrochloride (vitamin B1) is an essential coenzyme for carbohydrate metabolism. Severe deficiency causes Wernicke’s encephalopathy and Korsakoff syndrome, both of which require prompt parenteral administration because oral absorption is unreliable in at-risk populations.

Injection is preferred over oral supplementation when a patient has malabsorption, alcohol use disorder, or cannot tolerate oral forms. For staff who need guidance on scope and clinical oversight requirements, who can administer IV vitamin therapy covers the regulatory landscape by state.

• Thiamine deficiency (E51.x): primary indication for IV or IM thiamine; documented deficiency required by most MACs
• Wernicke’s encephalopathy (G37.3): neurological emergency; high-dose parenteral thiamine is standard of care
• Alcohol use disorder (F10.x): high risk for deficiency; prophylactic or therapeutic administration commonly covered
• Malabsorption syndromes (K90.x): oral route insufficient; parenteral route clinically justified
• Prolonged parenteral nutrition (E63.1): IV thiamine supplementation to prevent iatrogenic deficiency

Clinics offering IV nutritional therapy should review IV therapy clinic best practices for documentation and consent workflows that support medical necessity. Practices considering expanding this service line can also find operational guidance on opening an IV therapy clinic.

Medicare coverage and reimbursement for J3411

Medicare Part B covers provider-administered drugs, including thiamine HCl, under the buy-and-bill model. CMS reimburses J3411 at the Average Sales Price (ASP) plus 6%, updated quarterly. Because the ASP is recalculated each quarter, the allowable amount at the time of billing may differ from the amount in effect when the drug was purchased.

Understanding the basics of medical billing fundamentals helps front-office staff understand why the reimbursement amount can shift between quarters even for the same drug. Always check the CMS Physician Fee Schedule lookup for the current quarter’s allowable before filing claims.

J3411 fee schedule and ASP pricing

CMS publishes ASP drug pricing files quarterly (January, April, July, October). The J3411 allowable is expressed as a per-100-mg-unit amount. For 340B-enrolled providers, the payment is ASP minus 22.5%, not the standard ASP plus 6%. Conflating these two payment rates is a compliance risk. Providers in 340B programs should consult compliance counsel before applying the standard ASP rate to their claims.

Billing guidelines for HCPCS code J3411

Accurate claim submission for J3411 depends on getting four elements right: unit reporting, route documentation, place-of-service coding, and NDC inclusion. Missing any one of these is the most direct path to a denial. Practices that have systematised their drug-claim workflows report fewer rejections at first submission.

Pabau’s claims management software supports J-code billing by letting practices log the administered dose, map it to the correct HCPCS code, and attach the NDC before the claim leaves the system. That traceability is what auditors and MACs want to see when they review a J3411 claim.

• Units: report 1 unit per 100 mg administered. If 200 mg was given, report 2 units. Never round down.
• Route documentation: chart the administration route (IM or IV) explicitly. “Injection given” is insufficient for audit purposes.
• Place of service (POS): use POS 11 (office), POS 22 (outpatient hospital), or POS 49 (independent clinic) as appropriate. POS mismatch with the claim location is a common denial trigger.
• NDC reporting: Medicare requires the National Drug Code on every Part B drug claim. Format: NDC qualifier N4 followed by the 11-digit NDC, then the unit qualifier and quantity.
• Administration code: bill CPT 96372 (therapeutic IM injection) or CPT 96374 (IV push) alongside J3411 to capture the administration service separately from the drug cost.

Modifier requirements for J3411

CMS requires drug-waste modifiers on all J-code claims. The two applicable modifiers are JW and JZ. Getting these wrong causes automatic denial on Medicare claims.

CMS finalized mandatory JZ reporting as part of its effort to ensure drug-waste accountability. Verify the effective date and any MAC-specific requirements with your regional Medicare Administrative Contractor, as implementation timelines have varied by jurisdiction. Check the AAPC HCPCS code reference for the latest modifier guidance tied to J3411.

Buy and bill process for thiamine HCl

Under the buy-and-bill model, the practice purchases thiamine HCl directly from a supplier or wholesaler, administers it to the patient, and then bills Medicare or the commercial payer. The provider takes on the acquisition cost and cash-flow risk between purchase and reimbursement.

Practices that manage high volumes of injectable drugs benefit from systematic tracking. Understanding the broader context of revenue cycle management helps clinical staff see why each step in the buy-and-bill chain connects to cash flow. Mobile practices also face additional complexity; the workflow considerations for a mobile IV therapy business include temperature-controlled transport and point-of-care NDC documentation.

1. Purchase: acquire thiamine HCl 100 mg/mL vials from an approved wholesaler. Record the NDC, lot number, expiration date, and purchase price.
2. Store: maintain cold-chain requirements per the package insert. Document storage conditions in the drug log.
3. Administer: confirm the patient’s diagnosis supports medical necessity. Document the dose, route, administration time, and administering clinician.
4. Record NDC: capture the full 11-digit NDC from the vial label in the patient’s clinical record before disposal.
5. Bill: submit J3411 with the correct unit count, modifier (JW or JZ), NDC in N4 format, and the linked ICD-10 diagnosis code. Attach administration CPT code (96372 or 96374) on the same claim.

ICD-10 diagnosis codes for J3411 and covered diagnoses

Every J3411 claim must be linked to a supported ICD-10 diagnosis code. The specific codes accepted depend on your regional MAC’s Local Coverage Determination (LCD). The table below lists the most commonly accepted diagnoses; verify against your MAC’s active LCD before submitting, because coverage criteria vary by jurisdiction.

Maintaining strong medical billing compliance practices means documenting deficiency or clinical necessity in the chart before the claim is filed, not after a denial arrives.

Coverage for prophylactic use in alcohol use disorder and malabsorption syndromes is commonly supported but not universally guaranteed. Always reference your MAC’s LCD and document the clinical basis for each administration in the patient’s chart.

NDC to HCPCS J3411 crosswalk

Medicare Part B requires the National Drug Code (NDC) on every drug claim. The NDC identifies the specific manufacturer and package size of the drug administered. An 11-digit NDC in N4 format (with the unit qualifier and quantity) must appear on the claim line for J3411 or the claim will reject.

Always transcribe the NDC directly from the vial label administered to that patient on that date of service. NDC numbers vary by lot and package size. For a complete, current crosswalk, use the PGM Billing HCPCS lookup tool, which maps NDC codes to their corresponding HCPCS J-codes using current CMS data. The example NDCs above are representative; verify currency before submitting any claim.

Related HCPCS and CPT codes

Understanding J3411 in the context of adjacent codes prevents substitution errors and helps billers choose the right code when the clinical situation differs from the standard thiamine injection scenario.

Common billing errors and how to avoid them

Denials on J3411 claims cluster around five predictable mistakes. Each one is preventable with the right workflow controls in place.

Robust denial management in healthcare starts upstream, before the claim is filed. Once a denial arrives, the rework costs more time than the original submission. Practices should also review the reference guide to denial codes in medical billing so staff can interpret remittance advice and resubmit correctly.

• Incorrect unit count: billing 1 unit when 200 mg was administered (should be 2 units). Review the dose in the clinical chart against the claim line before submission.
• Missing or wrong modifier: omitting JW or JZ, or applying JW when there was no waste. Train staff to check the drug log at claim creation, not at billing time.
• NDC absent or malformatted: submitting without the NDC, or using a 10-digit NDC instead of the required 11-digit format. Use a billing template that enforces the N4 qualifier and 11-digit NDC field.
• Unsupported ICD-10 linkage: billing with a diagnosis code not covered under the MAC’s LCD for thiamine. Verify the diagnosis against the LCD before administering the drug, not after.
• Place-of-service mismatch: the POS on the claim does not match the physical location where the drug was administered. Review POS codes at each service location in your system settings.

Simplify J-code billing for your practice

Pabau helps IV therapy clinics and integrative medicine practices track administered drugs, attach NDCs, apply the right modifiers, and submit clean J-code claims without the spreadsheet juggling.

Book a demo

Conclusion

Thiamine HCl injection claims are straightforward in concept but denial-prone in execution. The unit definition (1 unit = 100 mg), the mandatory modifier pair (JW or JZ), the NDC reporting requirement, and the MAC-specific ICD-10 coverage rules all need to be right on the same claim simultaneously.

Practices that run IV therapy or integrative medicine services need a billing workflow that enforces these rules at the point of documentation, not after a denial comes back. Pabau’s claims management software builds these checks into the claim creation process so billers spend less time chasing rejections and more time on patient care. To see how it fits your practice’s J-code workflow, book a demo.

Continue your research

Managing a high-volume IV therapy service? Best EMR for IV therapy reviews the platforms most suited to injectable-drug documentation and billing workflows.

Need operational guidance for your IV clinic? IV therapy intake form covers the consent and screening documentation that supports medical necessity on drug claims.

Looking to understand the full billing cycle? What is a superbill? explains how superbills connect clinical documentation to HCPCS and CPT codes on the final claim.

Frequently Asked Questions